Many of the "new" brand name drugs promoted by pharmaceutical companies are nearly identical to ones already on the market. These "me too" drugs typically come with a steep price tag, driving up healthcare costs when they compete with available generics. Australian policy prohibits the addition of "me too" drugs to insurance formularies unless they demonstrate improved outcomes or lower costs. What would be the impact if the US were to adopt such a policy? Do you think the FDA should change its approval criteria for "addition to class" drugs?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.